In vitro differentiation of human parthenogenetic stem cells into neural lineages
Unfertilized human oocytes can be artificially activated by appropriate chemical stimuli to develop into parthenogenetic blastocysts. The inner cell mass of such blastocysts can be isolated and expanded as stable stem cell lines. First intentionally obtained by Revazova et al., human parthenogenetic stem cells (hpSCs) are similar to biparental human embryonic stem cells (hESCs) in their proliferation capacity and multilineage in vitro differentiation [1, 2] .
hpSCs can be either heterozygous or homozygous depending on the way the genome forms from the maternal chromosome set. Homozygous hpSCs may be useful as a source of cells for transplantations since the set of HLA genes in hpSC is able to produce differentiated derivatives less susceptible to immune rejection. Furthermore, if the HLA type is common, differentiated derivatives will match many millions of individuals [1, 3] . In addition to these immunogenetic advantages, as parthenogenesis does not involve the destruction of a viable human embryo, the use of hpSCs does not raise the same ethical concerns as conventional hESCs. Thus, hpSCs are an attractive alternative to other pluripotent stem cells as a source of somatic cell lines, including the multipotent neural stem cells (NSCs).
NSCs are self-renewing multipotent stem cells of the nervous system, which have the capacity to differentiate into neurons, oligodendrocytes and astrocytes [4] . NSCs can be obtained directly from a fetus and the adult CNS or by means of induced neural differentiation from pluripotent stem cells. NSCs are able to proliferate in vitro without losing their differentiation capacity for a relatively long time, and hence provide reserves of cell material for further applications. NSCs are considered to be a prospective therapy for neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, Huntington's disease and so on, as well as for immobility caused by spinal cord injuries. Successful experiments using animal models confirm efficiency of NSC therapy [5] .
The capacity to differentiate into neurons and glial cells was experimentally proved for mice [6] , primates [7] , and hpSCs [1, 2, 8] . Parthenogenetic stem cells bear two sets of maternally and no paternally imprinted genes, which is assumed to represent an obstacle for the differentiation into derivatives of all three germ layers. Experiments with chimeric animals reveal uneven selective processes, operating against parthenogenetic cells within certain differentiation pathways during fetal and postnatal development; at the Human parthenogenetic stem cells are derived from the inner cell mass of blastocysts obtained from unfertilized oocytes that have been stimulated to develop without any participation of male gamete. As parthenogenesis does not involve the destruction of a viable human embryo, the derivation and use of human parthenogenetic stem cells does not raise the same ethical concerns as conventional embryonic stem cells. Human parthenogenetic stem cells are similar to embryonic stem cells in their proliferation and multilineage in vitro differentiation capacity. The aim of this study is to derive multipotent neural stem cells from human parthenogenetic stem cells that are stable to passaging and cryopreservation, and have the ability to further differentiate into functional neurons. Immunocytochemistry, quantitative real-time PCR, or FACS were used to confirm that the derived neural stem cells express neural markers such as NES, SOX2 and MS1. The derived neural stem cells keep uniform morphology for at least 30 passages and can be spontaneously differentiated into cells with neuron morphology that express TUBB3 and MAP2, and fire action potentials. These results suggest that parthenogenetic stem cells are a very promising and potentially unlimited source for the derivation of multipotent neural stem cells that can be used for therapeutic applications. [9] . Cibelli et al. described the establishing of nonhuman primate Macaca fascicularis parthenogenetic stem cells called Cyno-1, and as proof of pluripotent state, Cyno-1 in vitro differentiation was performed, and neural derivatives, amongst others, were obtained [7] . Later, Sánchez-Pernaute et al. obtained dopamine neurons from Cyno-1 in vitro by means of directed differentiation, and demonstrated their effectiveness in Parkinson's disease models using rats and monkeys [10] . Neural differentiation of hpSCs in vitro was shown by Revazova et al. and Harness et al. [1, 2, 8] . Despite these studies, human parthenogenetic NSCs maintained in culture still have not been obtained.
We report here for the first time that NSCs derived from hpSCs (hpNSCs) are able to maintain proliferative and differentiation potential during cultivation and expansion, which enables practical amounts of neurogenic material to be obtained.
Materials & methods n Human parthenogenetic stem cells
The hpSC lines LLC2P, LLC6P and LLC12PH [1, 2] , were maintained on mitomycin-C inactivated mouse embryonic fibroblasts (Millipore) feeder layer in embryonic stem medium: KDMEM/F12 (Life Technologies), supplemented with 15% KSR (Life Technologies), 2 mM l-gluta mine (Gluta M A X™-I, Invitrogen), 0.1 mM MEM nonessential amino acids (Life Technologies), 0.1 mM b-mercaptoethanol (Life Technologies), penicillin/streptomycin/amphotericin B (100 U/100 µg/250 ng) (MP Biomedicals) and 5 ng/ml bFGF (Peprotech). Cells were passaged with dispase or collagenase IV (both Life Technologies) every 5-7 days with split ratio of 1:4 or 1:6. n Neural induction & NSCs Neural induction was done using an adherent culture system as described by Shin et al. [11] with modifications. Briefly, hpSCs maintained on mouse embryonic fibroblasts feeder layers for 5 days were passaged with dispase (Life Technologies) on CELLstart™ (Life Technologies) coated 60-mm petri dishes. During the next 4 days colonies of hpSCs were cultivated in embryonic stem medium, followed by culture in neural induction medium. Neural induction medium was DMEM/F12 containing N2 supplement (Life Technologies), 0.1 mM MEM nonessential amino acids, 2 mM l-glutamine (GlutaMAX-I, Life Technologies), antibiotic solution and 20 ng/ml of bFGF. The day of medium replacement was considered as day 0 of neural induction. The areas with wellformed rosettes of neuroepithelial cells were isolated mechanically, dissociated to single-cell suspensions using TrypLE™ (Life Technologies) and transferred into CELLstart-coated 24-well plates. Cells were expanded in StemPro ® NSC SFM medium (Invitrogen), supplemented with 20 ng/ml bFGF and 20 ng/ml EGF (both from Peprotech). Further expansion of NSCs was performed on CELLstart-coated 60-mm petri dishes in StemPro NSC SFM medium supplemented as described above. Cells were dissociated with Accutase ® (Life Technologies) during passaging. H9 hESC-derived NSCs (in this paper referred to as hNSCs; GIBCO ® Invitrogen) were maintained under the same conditions. Spontaneous differentiation of NSCs was performed in Neurobasal ® medium (Life Technologies), supplemented with B27 without retinol (Life Technologies), 0.1 mM MEM nonessential amino acids, 2 mM l-glutamine (GlutaMAX-I, Life Technologies) and antibiotic solution. For cryopreservation, NSCs were frozen in 10% DMSO in supplemented StemPro NSC SFM medium. n Real-time quantitative PCR Total RNA was isolated using the QIAsymphony ® automatic purification system, according to the manufacturer's instructions (Qiagen). Then, 100-500 ng total RNA was used for reverse transcription with the iScript™ cDNA synthesis kit (Biorad) . To analyze RNA quantities of specific genes, PCR reactions were performed in duplicate using 1/25th of the cDNA per reaction and the QuantiTect ® Primer Assay together with QuantiTect SYBR Green master mix (Qiagen) (primers listed in Table 1 ). Reverse transcriptase real-time quantitative PCR (qRT-PCR) was performed using the Rotor-Gene ® Q (Qiagen). Relative quantification was performed against a standard curve and quantified values were normalized against the input determined by PPIG. After normalization, the standard error of the mean was calculated (biological replica, n = 2-7). The results are presented as mean ± standard error of mean. Differences between data groups were determined using Student's t-test at p ≤ 0.05. n Immunocytochemistry For immunostaining, NSCs were fixed with 4% paraformaldehyde for 10 min at room temperature future science group and permeabilized by 0.1% Tween-20 and 0.3% Triton X-100 in phosphate buffered saline (PBS) for 1 h at room temperature. After permeabilization, the cells were blocked overnight at 4°C with 3% normal goat serum. Cells were then incubated overnight at 4°C with primary antibodies against Sox2 (1:100), Nestin (1:200) and Musashi-1 (1:300). Cells were washed threetimes with PBS and incubated with secondary antibodies (1:500) for 2 h at room temperature. For one-step staining of differentiated neurons, antitubulin bIII Alexa Fluor 488 coupled antibody was used according to the manufacturer's instruction (Covance). The nuclei were stained with DAPI. The list of primary and secondary antibodies is given in Table 2 . n Flow cytometry For FACS analysis, NSCs were harvested with Accutase, washed with PBS and fixed with 4% paraformaldehyde overnight at 4°C. NSCs were washed with PBS and incubated with primary antibodies against Musashi-1 (1:40) in a solution containing 0.1% Tween-20 and 1% normal goat serum in PBS for 1 h at room temperature. Cells were washed with PBS and incubated with secondary antibody conjugated to Alexa 488 (Table 2) for 1 h at room temperature. The samples were run on a Becton Dickinson FACSCalibur 
The overall objective of this study was to demonstrate that NSCs can be efficiently derived from hpSCs. For this purpose we have chosen the adherent model [11] , since it provides a more uniform and synchronous formation of neuroectoderm compared with the protocol using embryoid bodies [12] . Unlike the original protocol [11] , we did not use any feeder cells to grow stem cell After the medium was replaced, the first signs of neuroepithelial (NEP) rosettes appeared on the second day of neural induction. On the seventh day of neural induction, cell colonies appeared as large areas containing clusters of NEP rosettes. In these clusters most rosettes had well-formed lumen (Figure 1b) . qRT-PCR analysis revealed that transcriptional activity of the key neuroectodermal genes PAX6 and SOX1 were increased at this stage in comparison with undifferentiated hpSCs, whereas pluripotency marker OCT4 was dramatically downregulated ( Figure 1C ). The expression of specific neural marker genes NES and MS1 was also high. Endodermal marker AFP and mesodermal marker ACTA1 were not detected by qRT-PCR in the NEP rosettes (data not shown).
It is noteworthy that increased expression of SOX1 and SOX3 was observed in the hpSC-derived NEP rosettes, whereas a slight decrease of SOX2 expression was found (Figure 1C) , which might be associated with OCT4 down regulation [13] .
In this study, development of NEP rosettes in hpSC colonies grown on CELLstart occurred within a week after replacement of embryonic stem medium with neural induction medium. The early formation of the neuroepithelium in our model may be a result of the initial absence of feeder and/or the influence of CELLstart on the growing hpSC colonies. n hpNSC culture & phenotype The isolation and dissociation to single-cell suspension of NEP rosettes resulted in the hpNSC proliferating cell population. hpNSCs were passaged every 4-5 days at split ratio 1:2 over 5 months. hpNSCs maintained specific morphology similar to hNSCs for at least 30 passages The expression of specific genes SOX2, NES and MS1 in hpNSCs was confirmed at the protein level by immunocytochemical detection of corresponding antigens Sox2, Nestin and Musashi-1 (Figure 3) . We also compared transcriptional activity of the marker genes in five hpNSC lines, three heterozygous and two homozygous, with the hNSCs derived from H9 hESCs. The relative expression levels of NES, MS1 and PAX6 in hpNSC lines were close to those in hNSCs. The expression of pluripotency marker OCT4 was at detectable but very low levels in all NSC lines and the endodermal marker AFP was not detected (Figure 2b) .
We analyzed the expression of Musashi-1 by flow cytometry and found that more than 80% of the hpNSC population expresses Musashi-1 (Figure 2C) , which is consistent with previously published results on NSCs derived from hESCs [11] .
To support NSC proliferation growth factor bFGF is required, but this inhibits endogenous SHH, leading to a rapid loss of ability to differentiate into neurons, and promotes metamorphosis of NSCs into neural crest ectomesenchymal cells [14] . The expression levels of neural crest marker gene FOXD3 and mesodermal marker ACTA1 were low in hpNSCs up to 30 passages, and even lower in comparison with hNSCs (Figure 2b) . These data indicate the absence of large-scale metamorphosis of hNSCs into ectomesenchymal cells.
To demonstrate that hpNSCs can be preserved, we froze and thawed hpNSCs. The hpNSCs had the same morphology and proliferation rate after cryopreservation. The hpNSCs also expressed similar levels of the neural markers (Figure 4a & b) . Transcriptional activity of specific oligodendrocyte marker FOXO4 and astrocyte marker GFAP indicated the presence of glial derivatives among differentiated cells. n Electrophysiology of hpSC-derived neurons In the hpSC-derived neurons, action potentials were elicited by short (100-200 µs, 2-4 nA) bipolar current pulses, with an apparent threshold voltage for activation near -35 mV (Figure 4C) , an overshoot to +40 mV and a 95% duration of 4 ms. In spite of the high threshold voltage, which could implicate calcium current-dominant action potentials, the dominant inward currents that were observed from these same cells under voltage-clamp mode were from fast sodium channels. Figure 4D uses a voltage clamp waveform that hyperpolarizes the membrane to -100 mV to reset sodium channels, then steps to various sodium channel inactivating potentials between -90 and -45 mV to show the steady-state inactivation of sodium to a marginal test potential 
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future science group to -45 mV instead of -5 mV. The most negative sodium test potential was intended to demonstrate the presence of sodium currents separately from the presence of calcium currents and at the same time provide minimal activation of the outward potassium currents. Finally, the voltage was further stepped to various potentials between -120 and +60 mV to demonstrate the presence of any potassium currents, including inwardly rectifying (with activation at negative potentials), outwardly rectifying or transient outward currents (with activation above -40 mV). In addition, this last family of voltages will also activate any inward calcium currents since they will not become inactivated by voltages below -45 mV. This waveform, as illustrated in Figure 4D below the family of current recordings, revealed very little inward calcium current, but strong inward currents greater than 2 nA consistent in voltage dependence and temporal profile with fast sodium channels, and a quickly activating then slowly inactivating similarly sized outward current consistent with the voltage dependence and temporal profile of A-type potassium channels.
discussion
The main purpose of this study was to derive NSCs from hpSC lines. We successfully demonstrated future science group that pluripotent hpSCs can serve as a reliable source of NSCs. The hpNSCs obtained are capable of relatively stable proliferation while maintaining their neurogenic potential and ability to provide sufficient quantity of cells for cryopreservation and further study. We demonstrated that these hpNSCs express the same markers as NSCs derived from hESCs. We observed differences in gene expression between the homozygous and heterozygous hpNSC lines that could be due to differences between the original stem cell lines, or due to small variations in the derivation procedure. Further research would be required to understand these differences in gene expression. The differences observed between transcription activity of SOX1, SOX2 and SOX3 could be explained by the fact that these genes are members of SOXB1 subgroup of transcription factors whose exact role in the maintenance of neural progenitors and in restriction of their ability to differentiate still remains unclear. It was shown that the functions of these genes are redundant [13, 15] , thus it is possible that in maintaining the properties of NSCs, SOXB1 genes mutually compensate each other.
Based on gene expression data, the hpNSCs can be considered as precursors of all three main types of neural derivatives. At the same time, the expression of oligodendrocyte marker FOXO4 was higher in the differentiated neurons from hpNSCs compared with neurons derived from hNSCs. This finding correlated with higher expression of transcriptional factor OLIG2 specific for oligodendrocyte and neuron precursors future science group that hpNSCs could be a reliable source in the future for the treatment of neurodegenerative diseases.
Conclusion
The advantage of hpSCs is their ability to immune match millions of patients. hpSCs also overcome the ethical hurdle of hESCs by avoiding the destruction of viable human embryos. The successful derivation of NSCs from homozygous hpSCs represents a unique source of immunogenic stem cells for the treatment of multiple neurodegenerative diseases. 
